News

Pharmabiz7h
Eleva initiates patient dosing in phase 1 study of Factor H programme in C3-Glomerulopathy
Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced the first dosing in its phase 1 clinical study investigating the ...
Pharmabiz10h
US FDA accepts for review Berkshire Biomedical’s De Novo application for marketing authorization of COPA System
US FDA accepts for review Berkshire Biomedical’s De Novo application for marketing authorization of COPA System: Dallas, Texas Tuesday, July 8, 2025, 15:00 Hrs [IST] Berkshire B ...
Pharmabiz11h
Boehringer Ingelheim begins THULITE phase II study of BI 1815368, a potential oral treatment for diabetic macular edema
Ingelheim, Germany Tuesday, July 8, 2025, 14:00 Hrs [IST] ...
Pharmabiz8h
Sirtex Medical’s SIR-Spheres Y-90 resin microspheres receive US FDA nod to treat unresectable hepatocellular carcinoma
Sirtex Medical’s SIR-Spheres Y-90 resin microspheres receive US FDA nod to treat unresectable hepatocellular carcinoma: Woburn, Massachusetts Tuesday, July 8, 2025, 17:00 Hrs [I ...
Pharmabiz11h
Thalassemia India & TPAG recognize resilience of patients at Santosh & Arjun Dev Taneja Memorial Awards for Excellence 2025
Thalassemia India & TPAG recognize resilience of patients at Santosh & Arjun Dev Taneja Memorial Awards for Excellence 2025: Our Bureau, Bengaluru Tuesday, July 8, 2025, 13:30 Hrs ...
Pharmabiz11h
FIP World Pharmacists Day 2025 to highlight the vital role of pharmacists in sustainable healthcare systems
FIP World Pharmacists Day 2025 to highlight the vital role of pharmacists in sustainable healthcare systems: Our Bureau, Bengaluru Tuesday, July 8, 2025, 13:45 Hrs [IST] Internati ...
Pharmabiz10h
Bharat Serums and Mankind Pharma call for caution from snake bites during monsoons
Bharat Serums and Mankind Pharma have issued advisories on caution from snake bites. In a campaign titled ‘Saanp Ka Vaar, Aspatal Mein Hi Upchar!’ the companies highlighted the need to take timely and ...
Pharmabiz13h
HotSpot presents preclinical data from small molecule CBM signalosome inhibitor programme at ESMO Gastrointestinal Cancers Congress 2025
In combination with a KRAS inhibitor, HotSpot’s CBM signalosome inhibitor achieved complete suppression of downstream signalling in KRASG12X cell lines. HotSpot’s CBM signalosome inhibitor ...
Pharmabiz9h
Elekta & Gray partner to offer optimized oncology appointment scheduling for Elekta ONE OIS customers
Elekta & Gray partner to offer optimized oncology appointment scheduling for Elekta ONE OIS customers: Montréal Tuesday, July 8, 2025, 16:00 Hrs [IST] Gray Oncology Solutions, In ...
Pharmabiz12h
Sun Pharma confirms the stocks of 'Levipil 500' seized by Telangana DCA in raids is spurious
Sun Pharma confirms the stocks of 'Levipil 500' seized by Telangana DCA in raids is spurious: Our Bureau, Chennai Tuesday, July 8, 2025, 12:45 Hrs [IST] In a significant regulator ...
Pharmabiz16h
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases
Chugai Pharma and Gero sign joint research and license agreement to develop novel therapies for age-related diseases: Tokyo Tuesday, July 8, 2025, 09:00 Hrs [IST] Chugai Pharmaceu ...
Pharmabiz11h
Sai Parenterals secures Rs. 50 crore equity investment from marquee investors
Sai Parenterals secures Rs. 50 crore equity investment from marquee investors: Our Bureau, Bengaluru Tuesday, July 8, 2025, 13:15 Hrs [IST] Sai Parenterals has completed a Rs. 50 ...